Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Assist Reprod Genet ; 23(1): 47-9, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16447100

ABSTRACT

PURPOSE: To determine if GV oocytes, collected at the time of ICSI, can be matured in vitro and rescued for therapeutic treatment. A patient for whom all the collected oocytes at the GV stage after a classical COH protocol were matured in vitro with GH. METHOD: All the naked oocytes were matured in a culture medium (ISM2) containing 15% patient serum +1.6 units of GH (Saizen) per millilitre. Oocytes were incubated overnight at 37 degrees C. The MII oocytes obtained were micro-injected. A fresh transfer was performed and a supernumerary blastocyst was frozen. RESULTS: The patient was pregnant and delivered a healthy girl after transfer of the frozen/thawed blastocyst. The baby girl is now 2 years old. CONCLUSION: In vitro maturation with GH allows rescuing naked GV oocytes collected at the time of ICSI. GH action does not pass through the cumulus cells. According to the possible lack of synchrony between the embryo and the uterus, we recommend to freeze the embryos obtained and to replace them in a controlled cycle.


Subject(s)
Embryo Transfer , Growth Hormone/pharmacology , Oocytes/drug effects , Sperm Injections, Intracytoplasmic/methods , Adult , Blastocyst , Cryopreservation , Delivery, Obstetric , Female , Humans , Live Birth , Oocytes/transplantation , Pregnancy
2.
J Assist Reprod Genet ; 21(3): 89-90, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15202737

ABSTRACT

PURPOSE: To determine if hypergonadotropic hypogonadism related to galactosemia could be linked to anomaly of the circulating FSH. A 26-year-old woman, suffering GALT (Galactoso-1-phosphate uridyltransferase) had a premature ovarian failure with amenorrhea since the age of 19. The circulating level for FSH was 83 and 34 mU/mL for LH. METHODS: After treatment with a hormonal substitution cycle including estradiol and progesterone, the patient underwent stimulations with recombinant FSH. The first cycle, one 16-mm diameter follicle and the second cycle one follicle of 17.5 mm of diameter were obtained at the time of ovulation induction. RESULTS: The patient conceived and delivered a female baby weighting 3.38 kg after the second stimulation protocol. CONCLUSIONS: The impact of galactosemia on the ovary seems rather related to the absence of recognition of circulating FSH by its receptor and not to a toxic alteration of the ovary by itself as it is currently reported. The rFSH treatment following hormonal substitution cycles allows to overcome infertility problems.


Subject(s)
Follicle Stimulating Hormone/therapeutic use , Galactosemias/complications , Hypogonadism/complications , Infertility, Female/drug therapy , Adult , Delivery, Obstetric , Estradiol/therapeutic use , Female , Follicle Stimulating Hormone/blood , Galactosemias/enzymology , Humans , Infertility, Female/etiology , Ovulation Induction , Pregnancy , Pregnancy Outcome , Progesterone/therapeutic use , Recombinant Proteins/therapeutic use , UTP-Hexose-1-Phosphate Uridylyltransferase/deficiency
SELECTION OF CITATIONS
SEARCH DETAIL
...